Most Popular

    MacTel Project 2021 Update

    MacTel Project 2021 Update

    LOWY MEDICAL RESEARCH INSTITUTE - LMRI This past year has surely been an interesting and challenging one.  We hope that you and your family, friends, neighbors, and coworkers were able to weather the events safely. Despite the many challenges prese...

    Phase 3 Trial Currently Enrolling MacTel Patients

    Phase 3 Trial Currently Enrolling MacTel Patients

    In a collaboration with Neurotech Pharmaceuticals, the Lowy Medical Research Institute is currently enrolling a Phase 3 clinical trial testing ciliary neurotrophic factor (CNTF) in patients with macular telangiectasia type 2.  This is a multi-center...

    Neurotech Announces Positive Phase 2 Results in NT-501 (CNTF) for Macular Telangiectasia

    Neurotech Announces Positive Phase 2 Results in NT-501 (CNTF) for Macular Telangiectasia

    Neurotech Pharmaceuticals, Inc., in collaboration with the Lowy Medical Research Institute (LMRI), today announced 24-month results demonstrating that NT-501 delivering Ciliary Neurotrophic Factor (CNTF) has a beneficial effect in patients with Macul...